ACOG Updates Guidance on Menopause Symptom Management - Medscape

On average, caregivers want to see their children with ADHD fall asleep 30 minutes faster, but the best sleep treatments average approximately 20 minutes, a new survey study found. Caregivers of children with ADHD and sleep problems tend to place more weight on improving daytime ADHD symptoms than on improving sleep, and they expect treatment gains larger than current therapies typically deliver, according to a survey study published in the Journal of Attention Disorders. Alison Pritchard, Ph. D., a child clinical psychologist and co-director of the Center for Neuropsychological and Psychological Assessment at Kennedy Krieger Institute in Baltimore, was the lead author. The study, ‘What Matters to Caregivers of Youth With ADHD: Defining the Minimum Clinically Important Difference for Sleep Treatment,’ surveyed 100 caregivers in the waiting area of an outpatient department where children were being seen for psychological or neuropsychological evaluation. Approximately half of the families had commercial insurance and about half used medical assistance.

SARS-CoV-2 virus particles on a cell. Source: National Institute of Allergy and Infectious Diseases (NIAID) A large Long COVID review found mechanisms of “accelerated biological aging” in young adults. The review was published in Ageing Research Reviews and synthesized 110 mechanistic and epidemiological Long COVID studies on adults ages 25–55. The Chinese researchers found that inflammation and blood vessel damage may contribute to aging, while the disease may also increase the risk of early cardiovascular events. The review adds more evidence to the impact of infections on aging.

Analyzing facial images using a foundational artificial intelligence (AI) model may help researchers determine both biological aging and disease-related mortality risk, according to study findings published in The Lancet Digital Health. “As the population ages, physicians need better ways to estimate physical reserve and frailty before recommending intensive treatments such as radiation, surgery, or systemic therapy,” said co-corresponding author Raymond H. Mak, MD, a radiation oncologist at Mass General Brigham Cancer Institute and a faculty member in the Artificial Intelligence in Medicine (AIM) program at Mass General Brigham. “Our goal is to make face photograph–based health assessment more quantitative, consistent, and scalable so it can support personalized treatment decisions rather than replace physician judgment.”

A new preclinical study suggests that attacking triple-negative breast cancer (TNBC) in two ways at once can kill cancer cells, slow tumor growth and limit the cancer's spread. Researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James) developed the approach. The findings could help guide new treatments for this hard-to-treat form of breast cancer.

Take a look through some of the notable data presentations at this year's ESMO Congress. Related to this articleOctober 14th, 2026Delayed diagnosis and skipped nodal staging worsen penile cancer outcomes, according to Luis G. Medina, MD. Read moreOctober 20th, 2026The investigational HIF-2α inhibitor casdatifan demonstrated antitumor activity as monotherapy and in combination regimens across the ARC-20 platform study. Read moreOctober 19th, 2026The agency issued a PDUFA target action date of June 14, 2027. Read moreOctober 19th, 2026Jeffrey M. Spier, MD, reviews evidence on ARPI dose reduction in prostate cancer and discusses monitoring treatment response, tolerability, and dose reescalation. Read moreOctober 19th, 2026Jeffrey M. Spier, MD, discusses managing ARPI-related fatigue through dose adjustments, patient monitoring, and strategies to maintain treatment adherence. Read moreOctober 16th, 2026Long-term QUILT-3.032 findings show durable responses with Anktiva plus BCG in BCG-unresponsive NMIBC, with an estimated 84.2% cystectomy-free survival at 3 years.